AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.12
BATS BZX Real-Time Price
As of 1:28pm ET
 -0.04 / -1.85%
Today’s Change
1.76
Today|||52-Week Range
13.00
-81.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$16.7M

Company Description

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA.

Contact Information

AcelRx Pharmaceuticals, Inc.
25821 Industrial Boulevard
Hayward California 94545
P:(650) 216-3500
Investor Relations:
1650

Employees

Shareholders

Other institutional8.03%
Mutual fund holders4.44%
Individual stakeholders--

Top Executives

Vincent J. AngottiPresident, Chief Executive Officer & Director
Raffi AsadorianChief Financial & Accounting Officer
Pamela Pierce PalmerDirector & Chief Medical Officer
Badri N. DasuChief Engineering Officer
Mark A. EvashenkVice President-Clinical Operations